## **Trustees’ Annual Report for the period** **From 25/7/2023 Period start date To 31/7/2024 Period end date** **Charity name:** ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH ## **Charity registration number:** 1165453 ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|The advancement of health and relief of
sickness in the field of ear, nose and
throat/head and neck surgery and head
and neck disorders across the world in
particular but not exclusively by:
· Supporting the provision of awareness
and screening programmes
· Supporting cancer research by the
provision of grants
(AGA-ENT Charity Governing document -
version 1.1-21/1/2016)| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|· Supporting the provision of awareness
and screening programmes
· Supporting cancer research by the
provision of grants and support for UK and
international research| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|Yes, the trustees have had regard.| ## **Additional information (optional)** ## You may choose to include further statements where relevant about: SORP reference N/A Para 1.38 Policy on grant making N/A Para 1.38 Policy on social investment including program related investment |Contribution made by
volunteers|Para 1.38|Minor contributions, e.g. help with social
media.| |---|---|---| |Other||N/A| ## **Achievements and Performance** ||SORP reference|| |---|---|---| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|Our work has unfortunately been affected
by the pandemic, but we have continued
the fundraising in order to get the
programme established fully in 2023/4
again. We have supported fellows with
grants in the past and the travel
fellowships which had been awarded will
now be utilised in line with the aims and
objectives of the charity and continue to be
awarded for 2024.
After our BICRAA app (www.bicraa.org)
had been successfully tested in India
(n=1049), showing that around 30% chew
betel nut (we would like to thank Prof.
Kelkar and Dr. Pethe from the Deenanath
Mangeshkar Hospital, Pune, for their
invaluable support), the app has continued
to help raise the awareness of the risks of
betel nut chewing.
We have continued working on a global
study to extend these efforts in India and
other countries.
With regard to our work in Indonesia, we
have continued to closely work with our
partners at the Dr. Sardjito Hospital/Gadjah
Mada University in Yogyakarta, Indonesia,
and one of the trustees, Mr. Matt Lechner,
travelled there in September 2022 to
support the local Nasopharyngeal Cancer
(NPC) awareness and early detection
programme and to support research and
publications of results. The Storz company
has continued to support our programme
and in 2024 we were will be able to award
fellowship grants to young surgeons,
sponsored by a donation by Storz,
allowing them travel to low and middle
income countries and to help with the local
charitable work.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |Achievements against
objectives set|Para 1.41|As above. Taking the above work into
account AGA-ENT has made
contributions to the advancement of
health and relief of sickness in the field of
ear, nose and throat/head and neck
surgery and head and neck disorders in
low and middle income countries.
However, our work has unfortunately been
affected by the pandemic, but we have
aimed to continue the fundraising in order
to get the programme established fully in
2024. Held Annual Awards 2024.| |---|---|---| |Performance of fundraising
activities against objectives
set|Para 1.41|Good progress. Substantive funding will be
sought once the preliminary data are
published.| |Investment performance
against objectives|Para 1.41|N/A| |Other||N/A| ## **Financial Review** |**Financial Review**||| |---|---|---| |Review of the charity’s
financial position at the end
of the period|Para 1.21|31/7/2024| |Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|Year on year the charity hopes to
increase the reserves to be consistently in
line with 2 years possible commitments| |Amount of reserves held|Para 1.22|£15,660| |Reasons for holding zero
reserves|Para 1.22|N/A| |Details of fund materially in
deficit|Para 1.24|N/A| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|N/A| ## **Additional information (optional)** You may choose to include further statements where relevant about: |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|Donations by private and charity donors
and donated equipment.| |---|---|---| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|N/A| |A description of the principal
risks facing the charity|Para 1.46|At present funds are sufficient to achieve
the aims set, but more funding needs to be
sought to continue to expand our work.
Ensuring the ongoing income is the most
important risk we manage.| |Other||N/A| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|Constitution of the Association for the
Global Advancement of ENT Surgery and
Head and Neck Cancer Research (AGA-
ENT), a Charitable Incorporated
Organisation with voting members other
than its charity trustees
Date of constitution (last amended):
21/01/2016 (AGA-ENT Charity Governing
document - version 1.1 - 21/1/2016)| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|Charitable Incorporated Organisation| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|The current trustees volunteered to take on
these roles with the support of all founding
members and fulfil these roles in line with
the duties outlined in the AGA-ENT Charity
Governing document - version 1.1 -
21/1/2016| ## **Additional information (optional)** ## You may choose to include further statements where relevant about: |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|All duties outlined in the AGA-ENT Charity
Governing document - version 1.1 -
21/1/2016 and discussed during regular
Trustees’ meetings.| |---|---|---| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|Charitable Incorporated Organisation with
voting members other than its charity
trustees| |Relationship with any
related parties|Para 1.51|Collaborators and partners globally who
help to achieve the outlined objectives,
usually within the network of Founding
Members.| |Other||N/A| ## **Reference and Administrative details** Charity name Association for the Global Advancement of ENT Surgery and - Head and Neck Cancer Research (AGA ENT) Other name the charity uses AGA-ENT Registered charity number 1165453 |Charity’s principal address|Association for the Global Advancement of ENT Surgery
and Head and Neck Cancer Research (AGA-ENT), 4th
Floor, Eldon Chambers, 30-32 Fleet Street, London, EC4Y
1AA.| |---|---| ||| **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---| ||Paul O’Flynn||5/2/2016 – current date|Membershipbody| ||Matt Lechner||5/2/2016 – current date|Membershipbody| ||Valerie J. Lund||5/2/2016 – current date|Membershipbody| ||Francis M. Vaz||5/2/2016 – current date|Membershipbody| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ## – Corporate trustees names of the directors at the date the report was approved **Director name** N/A Name of trustees holding title to property belonging to the charity |**Trustee name**|**Dates acted if not for whole year**|| |---|---|---| |N/A||| |||| |||| |||| |||| |||| ## **Funds held as custodian trustees on behalf of others** Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** |**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**| |---|---|---| |**Type of**
**adviser**
**Name**
**Address**||| |N/A||| |||| |||| |||| |**Name of chief executive or names of senior staff members (Optional information)**||| |N/A||| N/A ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details The charity is too small still to employ personnel ## **Other optional information** N/A ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Mr. Matt Lechner **Position (eg Secretary,** Trustee **Chair, etc) Date** 07/02/2025 **Association for the Global Advancement of ENT Surgery 1165453 and Head and Neck Cancer Research Receipts and payments accounts CC16a For the period** 25/07/2023 **To** 31/07/2024 **from** ## **Section A Receipts and payments** |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**104,585**
**-**
**-**
**9**
**-**
**-**
**-**
**-**
**104,594**
**-**
**-**
**-**
**104,594**
**61**
**899**
**91,296**
**-**
**113**
**-**
**690**
**-**
**-**
**93,058**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**104,585**
**-**
**-**
**9**
**-**
**-**
**-**
**-**
**104,594**
**-**
**-**
**-**
**104,594**
**61**
**899**
**91,296**
**-**
**113**
**-**
**690**
**-**
**-**
**93,058**|**Last year**
**to the nearest £**| |---|---|---|---|---|---| |Donations|**104,585**||||**1,743**| ||**-**||||| ||**-**||||**-**| |Bank interest|**9**||||**5**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**104,594**||||**1,748**| ||||||| |**A2 Asset and investment sales,**
**(see table).**|||||| ||**-**||||| ||**-**||||**-**| |**_Sub total_**|**-**||||**-**| |**_Total receipts_**
**A3 Payments**|||||| ||||||**1,748**| ||||||| |Fundraisingcosts|**61**|**-**|**-**|**61**|**134**| |Web hostingand website costs|**899**|**-**|**-**|**899**|**40**| |Fellowships and Grants|**91,296**|**-**|**-**|**91,296**|**5,000**| |FundingApplication|**-**|**-**|**-**|**-**|**-**| |Office costs|**113**|**-**|**-**|**113**|**213**| |Travel expenses re: researchgrant|**-**|||**-**|**732**| |Legal andprofessional fees|**690**|**-**|**-**|**690**|**690**| |Sundryexpenses|**-**|**-**|**-**|**-**|**-**| ||**-**|**-**|**-**|**-**|**-**| |**_Sub total_ **|**93,058**|**-**|**-**|**93,058**|**6,809**| |Sundryexpenses
**_Sub total_ **|**-**
**-**
**93,058**||**-**
**-**
**-**||**-**
**-**
**-**|

||**-**
**-**
**93,058**||**-**
**-**
**6,809**| |---|---|---|---|---|---|---|---|---|---|---| |**A4 Asset and investment**||||||||||| |**purchases, (see table)**||||||||||| ||**-**||**-**|||**-**||**-**||| ||**-**||**-**|||**-**||**-**||| |**_Sub total_ **|**-**||**-**|||**-**||**-**||**-**| |||||||||||| |**_Total payments_**|**93,058**||**-**|||**-**||**93,058**||**6,809**| |**_Net of receipts/(payments)_**|**11,536**||**-**|||**-**||**11,536**||**- 5,062**| |**A5 Transfers between funds**|**-**||**-**||**-**|||**-**||**-**| |**A6 Cash funds last year end**|**4,124**||**-**||**-**|||**4,124**||**9,186**| |**_Cash funds this year end_**|**15,660**||**-**|||**-**||**15,660**||**4,124**| |||||||||||| 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B4 Assets retained for the**
**charity’s own use**
**B3 Investment assets**
**B2 Other monetary assets**
**B1 Cash funds**|**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
Bank accounts|**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
Bank accounts|**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
Bank accounts|**Unrestricted**
**funds**
**to nearest £**
**15,660**
**-**
**-**
**15,660**
OK
**Unrestricted**
**funds**
**to nearest £**|**Unrestricted**
**funds**
**to nearest £**
**15,660**
**-**
**-**
**15,660**
OK
**Unrestricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Endowment**
**funds**
**to nearest £**| |---|---|---|---|---|---|---|---|---| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||OK| |||||||||**Endowment**
**funds**
**to nearest £**| |||||**-**||**-**||**-**| |||||**-**||**-**||**-**| |||||**-**||**-**||**-**| |||||**-**||**-**||**-**| |||||**-**||**-**||**-**| |||||**-**||**-**||**-**| ||Signature
**Details**
**Details**
**Details**
Matt Lechner (Feb 7, 2025 17:54 GMT)|||**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
Print Name
**M Lechner**||||**Current value**
**(optional)**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**Current value**
**(optional)**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**-**| |||||||||**When due**
**(optional)**| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||Date of
approval| |||Matt Lechner (Feb 7, 2025 17:54 GMT)||**M Lechner**||||07/02/25| Signed by one or two trustees on behalf of all the trustees 2 ## AGA-ENT - CC16a - Accounts - y.e 31.07.24 Final Audit Report 2025-02-07 Created: 2025-02-07 By: Michelle Cox (michelle@kershen-fairfax.com) Status: Signed Transaction ID: CBJCHBCAABAAc1u5ZD8wN2WUynsCfcL2zgg2BPvhDpEj ## "AGA-ENT - CC16a - Accounts - y.e 31.07.24" History Document created by Michelle Cox (michelle@kershen-fairfax.com) 2025-02-07 - 5:06:10 PM GMT Document emailed to Matt Lechner (dr.matt.lechner@gmail.com) for signature 2025-02-07 - 5:06:14 PM GMT Email viewed by Matt Lechner (dr.matt.lechner@gmail.com) 2025-02-07 - 5:53:34 PM GMT Document e-signed by Matt Lechner (dr.matt.lechner@gmail.com) Signature Date: 2025-02-07 - 5:54:04 PM GMT - Time Source: server Agreement completed. 2025-02-07 - 5:54:04 PM GMT ## **Independent examiner's report on the accounts** ## **Section A Independent Examiner’s Report** ## **Report to the trustees/ members of** ## Charity Name Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research ## **On accounts for the year ended** 31[st] July 2024 **Charity no (if any)** 1165453 ## **Set out on pages** 1-2 (remember to include the page numbers of additional sheets) ## **Responsibilities and basis of report** I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/07/2024. As the charity trustees of the Trust, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”). I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. ## **Independent examiner's statement** I have completed my examination. I confirm that no material matters have come to my attention (other than that disclosed below *) in connection with the examination which gives me cause to believe that in, any material respect: - accounting records were not kept in accordance with section 130 of the Act or - the accounts do not accord with the accounting records I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. * _Please delete the words in the brackets if they do not apply._ **Signed:** **Date:** 07/02/2025 **Name:** M D Cox **Relevant professional qualification(s) or body (if any):** **October 2018** 1 **IER** ACA FCCA **Address:** c/o Kershen Fairfax Ltd, 4[th] Floor, Eldon Chambers 30-32 Fleet Street, London EC4Y 1AA **Section B Disclosure** Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners). **Give here brief details of any items that the examiner wishes to disclose** . **October 2018** 2 **IER**